2021
DOI: 10.3390/cells10112849
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future

Abstract: Malaria is still one of the major killer parasitic diseases in tropical settings, posing a public health threat. The development of antimalarial drug resistance is reversing the gains made in attempts to control the disease. The parasite leads a complex life cycle that has adapted to outwit almost all known antimalarial drugs to date, including the first line of treatment, artesunate. There is a high unmet need to develop new strategies and identify novel therapeutics to reverse antimalarial drug resistance de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 196 publications
(339 reference statements)
0
5
0
Order By: Relevance
“…1 Although there are clinically approved antimalarial agents in use, drug resistance has spread quickly and widely, and the limited availability of antimalarials has led many researchers to seek new antimalarials. 2–4…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1 Although there are clinically approved antimalarial agents in use, drug resistance has spread quickly and widely, and the limited availability of antimalarials has led many researchers to seek new antimalarials. 2–4…”
Section: Introductionmentioning
confidence: 99%
“…1 Although there are clinically approved antimalarial agents in use, drug resistance has spread quickly and widely, and the limited availability of antimalarials has led many researchers to seek new antimalarials. [2][3][4] In Plasmodium, thiamine 1 (Fig. 1) is converted into its active form, thiamine pyrophosphate (TPP) 2, by the enzyme thiamine pyrophosphokinase (TPK).…”
Section: Introductionmentioning
confidence: 99%
“…The aim of presenting these novel insights is to provide a valuable framework for future research investigating the importance of HSPs to schistosome growth, development, maturation and survival. In recent years, there has been an increased focus on HSPs in the field of disease research, with HSPs considered promising drug targets for infectious diseases and non-communicable diseases like cancer [ 65 68 ]. Several attributes of HSPs make them potential drug targets for the treatment of human schistosomiasis.…”
Section: Discussionmentioning
confidence: 99%
“…Unsatisfactory leishmaniasis treatment encourages researchers to investigate more modern options, which now target the parasite's functioning proteins or molecules. The heat shock protein 90 (Hsp90) is believed to be a commendable drug target against parasitic diseases (Debnath et al, 2014), (Stofberg et al, 2021), (O. Angel et al, 2013), (Silva et al, 2013), (De Andrade et al, 1992.…”
Section: Exploration Of the Potential Modulator To Modulate Autophagy...mentioning
confidence: 99%